What is the management of a patient with a subdural hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Subdural Hematoma

Surgical evacuation is indicated for acute subdural hematomas with thickness >5 mm and midline shift >5 mm, and this should be performed urgently to reduce mortality and improve functional outcomes. 1

Initial Assessment and Stabilization

Airway and Ventilation Management

  • Secure the airway immediately with tracheal intubation and mechanical ventilation, monitoring end-tidal CO₂ from the pre-hospital period onward. 1, 2, 3
  • Maintain PaCO₂ within normal range—avoid hypocapnia as it causes cerebral vasoconstriction and increases risk of brain ischemia. 1, 2, 3
  • End-tidal CO₂ monitoring confirms correct tube placement and guides ventilation targets. 1, 3

Hemodynamic Resuscitation

  • Maintain systolic blood pressure >110 mmHg using vasopressors (phenylephrine or norepinephrine) without delay. 3
  • Even a single episode of hypotension (SBP <90 mmHg) significantly worsens neurological outcomes. 3
  • Use continuous infusions of sedatives rather than boluses to prevent hemodynamic instability. 1, 3

Neurological Assessment

  • Perform complete neurological evaluation using Glasgow Coma Scale (GCS), pupillary examination, and focal neurological deficits. 2
  • Verify anticoagulant or antiplatelet use immediately, as these medications increase hematoma expansion risk. 2

Imaging

  • Obtain urgent non-contrast CT scan to characterize size, location, and mass effect of the hematoma. 2, 3
  • Use inframillimetric reconstructions with thickness >1mm, visualized with double window (CNS and bone). 3

Surgical Indications

Acute Subdural Hematoma

The following criteria mandate surgical evacuation: 1, 2

  • Hematoma thickness >5 mm with midline shift >5 mm
  • Any symptomatic subdural hematoma regardless of size
  • GCS ≤8 with significant mass effect
  • Progressive neurological deterioration

Timing of Surgery

  • While earlier surgery shows trends toward improved outcomes, the extent of underlying brain injury is more critical than absolute timing. 4
  • Emergency decompressive craniotomy in the emergency room may be performed when operating room availability is delayed, particularly for patients with GCS 3-4 and anisocoria. 5
  • No patient with initial subdural hematoma ≤3 mm required surgery, although 11% enlarged to maximum 10 mm. 6

Surgical Technique Options

  • Standard craniotomy with hematoma evacuation remains the first-line surgical approach. 1
  • For select patients with acute subdural hematoma who are GCS ≥13, hematoma thickness ≥7 mm, moderate deficits without progression, and no need for immediate evacuation, twist-drill craniostomy with pressure-controlled fibrinolytic irrigation achieved 90% independence (mRS 0-3) versus 56.7% with craniotomy. 7

Post-Operative Management

ICP Monitoring Indications

Monitor ICP after subdural hematoma evacuation if ANY of the following are present: 1

  • Preoperative GCS motor response ≤5
  • Preoperative anisocoria or bilateral mydriasis
  • Preoperative hemodynamic instability
  • Preoperative severity signs on imaging (compressed basal cisterns, midline shift >5 mm, other intracranial lesions)
  • Intraoperative cerebral edema
  • Postoperative appearance of new intracranial lesions

The rationale is strong: 50-70% of patients develop postoperative intracerebral hematoma, and >40% will have uncontrollable intracranial hypertension. 1

ICP and CPP Targets

  • Maintain cerebral perfusion pressure (CPP) between 60-70 mmHg. 1
  • CPP <60 mmHg is associated with poor outcomes. 1
  • CPP >70 mmHg increases respiratory distress syndrome risk 5-fold without improving neurological outcomes. 1
  • CPP >90 mmHg worsens outcomes due to aggravation of vasogenic cerebral edema. 1

Management of Intracranial Hypertension

For threatened intracranial hypertension or signs of brain herniation: 1

  • Use mannitol 20% or hypertonic saline at 250 mOsm dose, infused over 15-20 minutes after controlling secondary brain insults. 1
  • External ventricular drainage may be performed for persisting intracranial hypertension despite sedation and correction of secondary insults. 1, 2

Decompressive Craniectomy

  • Consider decompressive craniectomy for refractory intracranial hypertension in multidisciplinary discussion, particularly in patients <65-70 years. 1, 2
  • Large temporal craniectomy (>100 cm²) with enlarged dura mater plasty is the standard technique. 1
  • Good outcomes (GOS 4-5 at 6 months) occurred in 40-57% after unilateral craniectomy versus 28-32% in controls. 1

Postoperative Monitoring

  • Monitor for complications including seizures, infection, and hematoma expansion. 2
  • Subdural drain placement during surgery may reduce recurrence rates. 2
  • Maintain euvolemia and avoid hypovolemia to optimize cerebral perfusion. 2

Conservative Management

Indications for Non-Operative Management

Conservative management may be considered when ALL of the following are present: 2

  • No signs of intracranial hypertension
  • No neurological deterioration
  • Small hematoma with minimal mass effect
  • Specifically, hematomas ≤3 mm never required surgery in one large series, though 11% enlarged. 6

Monitoring Strategy

  • Close neurological observation with serial GCS, pupillary exams, and focal deficit assessments. 2
  • Repeat imaging for patients with risk factors for expansion: larger initial size, concurrent subarachnoid hemorrhage, hypertension, convexity location, and midline shift. 6
  • An 8.5 mm initial subdural hematoma size threshold best predicted need for surgical intervention (AUC 0.81). 6

Adjunctive Medical Therapies

  • Dexamethasone should be used with caution in selected patients given side effects. 8
  • Tranexamic acid may be utilized as adjunct to surgery, but more randomized trials are needed. 8
  • Middle meningeal artery embolization shows interesting results but risks (intracerebral hemorrhage, stroke, vasospasm) are not well-studied. 8

Special Populations

Elderly Patients

  • Require careful monitoring as small hematomas can expand rapidly, especially in those on anticoagulants. 2
  • Elderly patients are prone to poor surgical outcomes and complications. 8

Subacute Subdural Hematoma

  • Same surgical thresholds apply (thickness >5 mm, midline shift >5 mm). 2
  • Conservative management appropriate for small hematomas without mass effect or neurological deterioration. 2

Critical Pitfalls to Avoid

  • Delaying surgical intervention in symptomatic patients leads to neurological deterioration and poorer outcomes. 2
  • Using sedation boluses instead of continuous infusions causes hemodynamic instability. 3
  • Allowing hypocapnia, which induces cerebral vasoconstriction and brain ischemia. 2, 3
  • Permitting even single episodes of hypotension (SBP <90 mmHg), which markedly worsens prognosis. 3
  • Delaying transfer to neurosurgical center for "stabilization" in facilities without neurosurgery. 3

Prognostic Factors

The following factors predict worse outcomes: 4

  • Age >65 years
  • Admission GCS 3-4
  • Postoperative ICP >45 mmHg
  • Motorcycle accident mechanism

The extent of primary underlying brain injury is more important than the subdural clot itself in dictating outcome; therefore, aggressive ICP control is more critical than absolute timing of clot removal. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.